Your browser doesn't support javascript.
loading
Central effects of urotensin-II following ICV administration in rats.
Gartlon, J; Parker, F; Harrison, D C; Douglas, S A; Ashmeade, T E; Riley, G J; Hughes, Z A; Taylor, S G; Munton, R P; Hagan, J J; Hunter, J A; Jones, D N.
Affiliation
  • Gartlon J; Neuroscience Research, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK. jane_gartlon-1@sbphrd.com
Psychopharmacology (Berl) ; 155(4): 426-33, 2001 Jun.
Article in En | MEDLINE | ID: mdl-11441433
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urotensins / Behavior, Animal / Central Nervous System / Receptors, G-Protein-Coupled Limits: Animals Language: En Journal: Psychopharmacology (Berl) Year: 2001 Document type: Article Affiliation country: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urotensins / Behavior, Animal / Central Nervous System / Receptors, G-Protein-Coupled Limits: Animals Language: En Journal: Psychopharmacology (Berl) Year: 2001 Document type: Article Affiliation country: Reino Unido